CASI Pharmaceuticals, Inc (DE) — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2022)
- $43.1M
- Net Income/Loss (FY2022)
- -$40.3M
- Total Assets (FY2022)
- $96.2M
- Total Equity (FY2022)
- $44.6M
- Cash Flows from Operating Activities (FY2022)
- -$21.1M
Source: CASI Pharmaceuticals, Inc (DE) 20-F filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
